Inhibitory CD8+ T cells in autoimmune disease

Gershon, 1970, Cell interactions in the induction of tolerance: The role of thymic lymphocytes, Immunology, 18, 723

Sakaguchi, 1995, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25), J Immunol, 155, 1151, 10.4049/jimmunol.155.3.1151

Cools, 2007, Regulatory T cells and human disease, Clin Dev Immunol, 2007, 89195, 10.1155/2007/89195

Rouse, 2007, Regulatory T cells in health and disease, J Intern Med, 262, 78, 10.1111/j.1365-2796.2007.01836.x

Valencia, 2007, CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases, Nat Clin Pract Rheumatol, 3, 619, 10.1038/ncprheum0624

Akbar, 2007, The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery, Nat Rev Immunol, 7, 231, 10.1038/nri2037

Roncarolo, 2006, Interleukin-10-secreting type 1 regulatory T cells in rodents and human beings, Immunol Rev, 212, 28, 10.1111/j.0105-2896.2006.00420.x

Weiner, 2001, Oral tolerance, Microbes Infect, 3, 947, 10.1016/S1286-4579(01)01456-3

Liu, 1998, Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28− T cells, Int Immunol, 10, 775, 10.1093/intimm/10.6.775

Ciubotariu, 1998, Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+CD28− regulatory T cells, J Immunol, 161, 5193, 10.4049/jimmunol.161.10.5193

Jiang, 1998, Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro, Hum Immunol, 59, 690, 10.1016/S0198-8859(98)00073-1

Chang, 2002, Tolerization of dendritic cells by T(S) cells: The crucial role of inhibitory receptors ILT3 and ILT4, Nat Immunol, 3, 237, 10.1038/ni760

Uss, 2006, CD103 is a marker for alloantigen-induced regulatory CD8+ T cells, J Immunol, 177, 2775, 10.4049/jimmunol.177.5.2775

Mahic, 2008, Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation, Eur J Immunol, 38, 640, 10.1002/eji.200737529

Bisikirska, 2005, TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs, J Clin Invest, 115, 2904, 10.1172/JCI23961

Jarvis, 2005, Autoreactive human peripheral blood CD8+ T cells with a regulatory phenotype and function, Eur J Immunol, 35, 2896, 10.1002/eji.200526162

Gilliet, 2002, Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells, J Exp Med, 195, 695, 10.1084/jem.20011603

Wei, 2005, Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma, Cancer Res, 65, 5020, 10.1158/0008-5472.CAN-04-4043

Gray, 1998, Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGFbeta: Contrasting effects of anti-CD2 and anti-CD3, J Immunol, 160, 2248, 10.4049/jimmunol.160.5.2248

Billerbeck, 2007, Parallel expansion of human virus-specific FoxP3- effector memory and de novo-generated FoxP3+ regulatory CD8+ T cells upon antigen recognition in vitro, J Immunol, 179, 1039, 10.4049/jimmunol.179.2.1039

Joosten, 2007, Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4, Proc Natl Acad Sci U S A, 104, 8029, 10.1073/pnas.0702257104

Dhodapkar, 2002, Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in human beings, Blood, 100, 174, 10.1182/blood.V100.1.174

Filaci, 2004, Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28− T cells and inhibit both T-cell proliferation and CTL function, Hum Immunol, 65, 142, 10.1016/j.humimm.2003.12.001

Filaci, 2005, Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation, Ann N Y Acad Sci, 1050, 115, 10.1196/annals.1313.013

Cosmi, 2003, Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes, Blood, 102, 4107, 10.1182/blood-2003-04-1320

Endharti, 2005, Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFNgamma production and aproliferation of CD8+ T cells, J Immunol, 175, 7093, 10.4049/jimmunol.175.11.7093

Suzuki, 1995, Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta, Science, 268, 1472, 10.1126/science.7770771

Rifa'i, 2004, Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis, J Exp Med, 200, 1123, 10.1084/jem.20040395

Lee, 2008, Essential role of CD8+CD122+ regulatory T cells in the recovery from experimental autoimmune encephalomyelitis, J Immunol, 180, 825, 10.4049/jimmunol.180.2.825

Chess, 2004, Resurrecting CD8+ suppressor T cells, Nat Immunol, 5, 469, 10.1038/ni0504-469

Li, 2001, Induction of TCR Vbeta-specific CD8+ CTLs by TCR Vbeta-derived peptides bound to HLA-E, J Immunol, 167, 3800, 10.4049/jimmunol.167.7.3800

Lu, 2006, The immunoregulatory effects of Qa-1, Immunol Rev, 212, 51, 10.1111/j.0105-2896.2006.00418.x

Sarantopoulos, 2004, Qa-1 restriction of CD8+ suppressor T cells, J Clin Invest, 114, 1218, 10.1172/JCI23152

Correale, 2008, Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis, J Neuroimmunol, 195, 121, 10.1016/j.jneuroim.2007.12.004

Tennakoon, 2006, Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis, J Immunol, 176, 7119, 10.4049/jimmunol.176.11.7119

Hu, 2004, Analysis of regulatory CD8 T cells in Qa-1-deficient mice, Nat Immunol, 5, 516, 10.1038/ni1063

Jiang, 1998, T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells, Proc Natl Acad Sci U S A, 95, 4533, 10.1073/pnas.95.8.4533

Jiang, 1995, Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing V beta 8 TCR: A role of the Qa-1 molecule, Immunity, 2, 185, 10.1016/S1074-7613(95)80079-4

Niederkorn, 2008, Emerging concepts in CD8(+) T regulatory cells, Curr Opin Immunol, 20, 327, 10.1016/j.coi.2008.02.003

Chung, 2007, Atherosclerosis and inflammation: Insights from rheumatoid arthritis, Clin Rheumatol, 26, 1228, 10.1007/s10067-007-0548-7

Goronzy, 2005, Rheumatoid arthritis, Immunol Rev, 204, 55, 10.1111/j.0105-2896.2005.00245.x

Weyand, 2007, Immunopathologic aspects of rheumatoid arthritis: Who is the conductor and who plays the immunologic instrument?, J Rheumatol Suppl, 79, 9

Weyand, 2003, Ectopic germinal center formation in rheumatoid synovitis, Ann N Y Acad Sci, 987, 140, 10.1111/j.1749-6632.2003.tb06042.x

Gravallese, 2002, Bone destruction in arthritis, Ann Rheum Dis, 61, ii84, 10.1136/ard.61.suppl_2.ii84

Tran, 2005, Synovial biology and T cells in rheumatoid arthritis, Pathophysiology, 12, 183, 10.1016/j.pathophys.2005.07.005

Manadan, 2008, Rheumatoid arthritis: Beyond tumor necrosis factor-alpha antagonists, B cell depletion, and T cell blockade, Am J Ther, 15, 53, 10.1097/MJT.0b013e31814daf9b

Ostor, 2005, Beyond methotrexate: Biologic therapy in rheumatoid arthritis, Clin Med, 5, 222, 10.7861/clinmedicine.5-3-222

Davila, 2005, Cell-based immunotherapy with suppressor CD8+ T cells in rheumatoid arthritis, J Immunol, 174, 7292, 10.4049/jimmunol.174.11.7292

Klimiuk, 1999, IL-16 as an anti-inflammatory cytokine in rheumatoid synovitis, J Immunol, 162, 4293, 10.4049/jimmunol.162.7.4293

Haughn, 1992, Association of tyrosine kinase p56lck with CD4 inhibits the induction of growth through the alpha beta T-cell receptor, Nature, 358, 328, 10.1038/358328a0

Theodore, 1996, CD4 ligand IL-16 inhibits the mixed lymphocyte reaction, J Immunol, 157, 1958, 10.4049/jimmunol.157.5.1958

McFadden, 2007, Preferential migration of T regulatory cells induced by IL-16, J Immunol, 179, 6439, 10.4049/jimmunol.179.10.6439

Seo, 2004, 4-1BB-mediated immunotherapy of rheumatoid arthritis, Nat Med, 10, 1088, 10.1038/nm1107

Krug, 2008, Nucleic acid recognition receptors in autoimmunity, Handb Exp Pharmacol, 129, 10.1007/978-3-540-72167-3_7

Martinez Valle, 2008, DNase 1 and systemic lupus erythematosus, Autoimmun Rev, 7, 359, 10.1016/j.autrev.2008.02.002

McMahona, 2007, Atherosclerosis and systemic lupus erythematosus: Mechanistic basis of the association, Curr Opin Immunol, 19, 633, 10.1016/j.coi.2007.11.001

Filaci, 2001, Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus, J Immunol, 166, 6452, 10.4049/jimmunol.166.10.6452

Hahn, 2001, Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus, Arthritis Rheum, 44, 432, 10.1002/1529-0131(200102)44:2<432::AID-ANR62>3.0.CO;2-S

La Cava, 2004, Ig-reactive CD4+CD25+ T cells from tolerized (New Zealand Black x New Zealand White)F1 mice suppress in vitro production of antibodies to DNA, J Immunol, 173, 3542, 10.4049/jimmunol.173.5.3542

Hahn, 2005, Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFbeta-secreting CD8+ T cell suppressors, J Immunol, 175, 7728, 10.4049/jimmunol.175.11.7728

Singh, 2008, pConsensus peptide induces tolerogenic CD8+ T cells in lupus-prone (NZB x NZW)F1 mice by differentially regulating Foxp3 and PD1 molecules, J Immunol, 180, 2069, 10.4049/jimmunol.180.4.2069

Singh, 2007, CD8+ T cell-mediated suppression of autoimmunity in a murine lupus model of peptide-induced immune tolerance depends on Foxp3 expression, J Immunol, 178, 7649, 10.4049/jimmunol.178.12.7649

Kang, 2005, Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets, J Immunol, 174, 3247, 10.4049/jimmunol.174.6.3247

Zheng, 2004, CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGFbeta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome, J Immunol, 172, 1531, 10.4049/jimmunol.172.3.1531

Sartor, 2008, Microbial influences in inflammatory bowel diseases, Gastroenterology, 134, 577, 10.1053/j.gastro.2007.11.059

Maloy, 2008, The Interleukin-23/Interleukin-17 axis in intestinal inflammation, J Intern Med, 263, 584, 10.1111/j.1365-2796.2008.01950.x

van Driel, 2008, Role of regulatory T cells in gastrointestinal inflammatory disease, J Gastroenterol Hepatol, 23, 171, 10.1111/j.1440-1746.2007.05278.x

Allez, 2002, Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells, Gastroenterology, 123, 1516, 10.1053/gast.2002.36588

Brimnes, 2005, Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease, J Immunol, 174, 5814, 10.4049/jimmunol.174.9.5814

Singh, 2001, Control of intestinal inflammation by regulatory T cells, Immunol Rev, 182, 190, 10.1034/j.1600-065X.2001.1820115.x

Kontoyiannis, 1999, Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies, Immunity, 10, 387, 10.1016/S1074-7613(00)80038-2

Ho, 2008, A CD8+/CD103high T cell subset regulates TNFmediated chronic murine ileitis, J Immunol, 180, 2573, 10.4049/jimmunol.180.4.2573

Menager-Marcq, 2006, CD8+CD28− regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice, Gastroenterology, 131, 1775, 10.1053/j.gastro.2006.09.008

Rapoport, 2007, The thyrotropin receptor in Graves' disease, Thyroid, 17, 911, 10.1089/thy.2007.0170

Saitoh, 2007, CD8+CD122+ T cells, a newly identified regulatory T subset, negatively regulate Graves' hyperthyroidism in a murine model, Endocrinology, 148, 6040, 10.1210/en.2007-0300

Atassi, 1997, Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides, Crit Rev Immunol, 17, 481

Ben-David, 2007, The role of CD8+CD28 regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand, Proc Natl Acad Sci U S A, 104, 17459, 10.1073/pnas.0708577104

Romero, 2007, Four functionally distinct populations of human effector-memory CD8+ T lymphocytes, J Immunol, 178, 4112, 10.4049/jimmunol.178.7.4112

Kelly-Rogers, 2006, Activation-induced expression of CD56 by T cells is associated with a reprogramming of cytolytic activity and cytokine secretion profile in vitro, Hum Immunol, 67, 863, 10.1016/j.humimm.2006.08.292

Michel, 2007, CD56-expressing T cells that have features of senescence are expanded in rheumatoid arthritis, Arthritis Rheum, 56, 43, 10.1002/art.22310

Gavin, 2006, Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development, Proc Natl Acad Sci U S A, 103, 6659, 10.1073/pnas.0509484103

Roncarolo, 2008, Is FOXP3 a bona fide marker for human regulatory T cells?, Eur J Immunol, 38, 925, 10.1002/eji.200838168

Vlad, 2005, License to heal: Bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC, J Immunol, 174, 5907, 10.4049/jimmunol.174.10.5907

Pillai, 2007, Transient regulatory T-cells: A state attained by all activated human T-cells, Clin Immunol, 123, 18, 10.1016/j.clim.2006.10.014